Search
Descriptor English: Betamethasone
Descriptor Spanish: Betametasona
Descriptor betametasona
Entry term(s) betadexametasona
flubenisolona
Scope note: Glucocorticoesteroide que se administra por vía oral, parenteral, por inyección local, por inhalación, o aplicada tópicamente, en el tratamiento de diversos trastornos en los que están indicados los corticoesteroides. Por carecer de propiedades mineralocorticoides, la betametasona resulta particularmente adecuada para tratar el edema cerebral y la hiperplasia suprarrenal congénita. (Martindale, The Extra Pharmacopoeia, 30th ed, p724)
Descriptor Portuguese: Betametasona
Descriptor French: Bétaméthasone
Entry term(s): Betadexamethasone
Celeston
Celestona
Celestone
Cellestoderm
Flubenisolone
Tree number(s): D04.210.500.745.432.769.199
D04.210.500.908.093
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D001623
Scope note: A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Inflammatory Agents
Glucocorticoids
Anti-Asthmatic Agents
Registry Number: 9842X06Q6M
CAS Type 1 Name: Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-
Public MeSH Note: 64
History Note: 64(63)
DeCS ID: 22355
Unique ID: D001623
NLM Classification: WK 755
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1964/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/05/27
Betamethasone - Preferred
Concept UI M0002437
Scope note A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
Preferred term Betamethasone
Entry term(s) Betadexamethasone
Flubenisolone
Celestona - Narrower
Concept UI M0372305
Preferred term Celestona
Cellestoderm - Narrower
Concept UI M0372307
Preferred term Cellestoderm
Celeston - Narrower
Concept UI M0372306
Preferred term Celeston
Celestone - Narrower
Concept UI M0372304
Preferred term Celestone



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey